Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Alawi Habara, MBBS, MSc, Cuong LE, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, Shuaiying Cui, PhD

Blood (2019) 134 (Supplement_1): 2254.

https://doi.org/10.1182/blood-2019-123959

Published: 2019

Journal Articles

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

Alawi Habara, MBBS, MSc, Cuong LE, PhD, George J Murphy, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, Shuaiying Cui, PhD

Blood (2018) 132 (Supplement 1): 2358.

https://doi.org/10.1182/blood-2018-99-111022

Published: 2018

Journal Articles

LSD1 Inhibitors Induce Fetal Hemoglobin in Primary Human Erythroid Cells

Cuong LE, PhD, Greggory Myers, Alawi Habara, MBBS, MSc, David H.K. Chui, MD, Martin H. Steinberg, MD, James Douglas Engel, PhD, Shuaiying Cui, PhD

Blood (2018) 132 (Supplement 1): 1066.

https://doi.org/10.1182/blood-2018-99-117675

Published: 2018

Journal Articles

A Long Noncoding RNA from the HBS1L-MYB Intergenic Region on Chr6q23 Regulates Human Fetal Hemoglobin Expression

Tasha A. Morrison, MPH,BA, Ibifiri Wilcox, BS, Hong-Yuan Luo, PhD, John Farrell, PhD, Ryo Kurita, PhD, Yukio Nakamura, MD PhD, George J Murphy, PhD, Shuaiying Cui, PhD, Martin H. Steinberg, MD, David H.K. Chui, MD

Blood (2017) 130 (Supplement 1): 288.

https://doi.org/10.1182/blood.V130.Suppl_1.288.288

Published: 2017

Journal Articles

In Vivo Effects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice

Cuong Le, PhD, Greggory Myers, Alawi Habara, Natee Jearawiriyapaisarn, PhD, Mary Lee, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, James Engel, PhD, Shuaiying Cui, PhD

Blood (2017) 130 (Supplement 1): 968.

https://doi.org/10.1182/blood.V130.Suppl_1.968.968

Published: 2017

Journal Articles

Activity of RN-1, an LSD-1 Inhibitor, on Fetal Globin Expression in Sickle Mice and Sickle Erythroid Progenitors

Shuaiying Cui, PhD, Jose Sangerman, PhD, Seyed Mehdi Nouraie, MD, PhD, Yan Dai, PhD, Oluwakemi Owoyemi, MD MPH, Robert E. Taylor, MD PhD, Susan P. Perrine, MD

Blood (2015) 126 (23): 961.

https://doi.org/10.1182/blood.V126.23.961.961

Published: 2015

NARROW

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

LSD1 Inhibitors Induce Fetal Hemoglobin in Primary Human Erythroid Cells

A Long Noncoding RNA from the HBS1L-MYB Intergenic Region on Chr6q23 Regulates Human Fetal Hemoglobin Expression

In Vivo Effects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice

Activity of RN-1, an LSD-1 Inhibitor, on Fetal Globin Expression in Sickle Mice and Sickle Erythroid Progenitors

Email alerts

ASH Publications

American Society of Hematology

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

LSD1 Inhibitors Induce Fetal Hemoglobin in Primary Human Erythroid Cells

A Long Noncoding RNA from the HBS1L-MYB Intergenic Region on Chr6q23 Regulates Human Fetal Hemoglobin Expression

In Vivo Effects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice

Activity of RN-1, an LSD-1 Inhibitor, on Fetal Globin Expression in Sickle Mice and Sickle Erythroid Progenitors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only